. In addition, the new winning projects had decreased. Investments in joint ventures decreased by 17.6 MB or decrease of 17.2%, due to the recognition of share of loss from joint venture ‘s performance

in prepaid maintenance expenses, which those had decreased with the period of service. Investments in joint ventures decreased by 25.4 MB or decrease of 24.8%, due to the recognition of share of loss

2,311.5 2,457.1 Gross margin, % 23.99% 20.36% 21.09% SG & A 429.9 372.4 403.1 Net Profit per F/S 424.8 251.8 +68.7% 268.6 +58.2% 13.03% 8.68% 8.63% Sales Revenue Consolidated sales revenue in Baht terms

sales staffs, advertising media fee for product promotion, distribution fee paid to Zuellig Pharma Ltd. under the Distribution Agreement and compensation for distribution of company’ s products in the

1.0% 4.5% 27,814 27,229 2.1% Earnings per share (Baht) 4.94 4.90 4.73 1.0% 4.5% 14.57 14.26 2.1% Net interest margin 2.35% 2.36% 2.42% (0.01)% (0.07)% 2.39% 2.38% 0.01% Net fees and service income to

163.17 42.9% 202.75 46.0% 39.58 24.3% SG&A 58.51 15.4% 83.78 19.0% 25.27 43.2% EBIT 104.66 27.5% 118.97 27.0% 14.31 13.7% Share of Gain in Associates - - 0.51 0.1% 0.51 - Interest Expenses 0.48 0.1% 0.35

สามัญ (Common Stock) “หุ้นสามัญ”ที่ออกเพื่อเสนอขายให้แก่ผู้ลงทุนที่ต้องการเข้ามาร่วมเป็นเจ้าของกิจการ โดยเป็นการเสนอขายให้ผู้ลงทุนในวงจำกัด (Private Placement) เท่านั้น Share on : ท่านทราบหรือไม่ว่า หาก

Stock Exchange of Thailand Reference: Letter No. OP. 435/ 2019 dated 12 December 2019 on the entering into the Conditional Share Purchase Agreement for the acquisition of a majority shareholding in PT

of 2019 – touching Baht 30.73/USD, the strongest level in six years. The stronger Thai Baht was seen after the Federal Reserve’ s May 1, 2019 meeting resolved to keep its policy rate intact against the

Memorandum concerning the Connected Transaction of the Offering and Allocation of the Newly Issued Shares of Hydrotek Public Company Limited Following Hydrotek Public Company Limited (the “Company”)’s Board of